Search

Displaying results 531 - 540 of 10000 in total
  1. Drug

    Fosfomycin

    go.drugbank.com/drugs/DB00828
    ApprovedInvestigational

    [A229338,A230348] It may also be produced synthetically and is commercially available as the disodium salt for intravenous administration and as the calcium or trometamol salt for oral administration. … [A230348] As such there is great interest in exploring the usefulness of fosfomycin for indications beyond the treatment of UTIs.[A230353,A230358]

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseSynonyms: (1R,2S)-epoxypropylphosphonic acid, cis-(1R,2S)-epoxypropylphosphonic acid
  2. Drug

    Propofol

    go.drugbank.com/drugs/DB00818
    ApprovedInvestigationalVet approved

    Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. … IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications.

    Mixtures: Anesthesia S/I-60, Anesthesia S/I-40Products: PROPOFOL USP 200MG/20ML EMULSION INYECTABLE, PROPOFOL USP 100 MG/10 ML EMULSION INYECTABLE
  3. Drug

    Nifedipine

    go.drugbank.com/drugs/DB01115
    ApprovedInvestigational

    Nifedipine, or BAY a 1040, is a first generation dihydropyridine L-type calcium channel blocker, similar to [nicardipine]. … [A190273] The most popular of the third generation dihydropyridines is [amlodipine].[A190273] Nifedipine was granted FDA approval on 31 December 1981.[L11383]

    Products: Gen Nifedipine Cap 10mg USP, NICARDIA-XL-30 (NIFEDIPINE EXTENDED RELEASE TABLETS USP 30MG)
  4. Drug

    Dipropylene glycol

    go.drugbank.com/drugs/DB14140
    Investigational

    Products: Abelia pomegranate bounce up mask
  5. Drug

    Haloperidol

    go.drugbank.com/drugs/DB00502
    ApprovedInvestigational

    However, haloperidol use remains widespread and is considered the benchmark for comparison in trials of the newer generation antipsychotics. … However, this class of drugs is also limited by the development of movement disorders induced by dopamine-blockade such as drug-induced parkinsonism, akathisia, dystonia, tardive dyskinesia, as well as

    International brands: Einalon SProducts: Haloperidol Inj 5mg/ml USP, Haloperidol Injection, USP
  6. Drug

    Midazolam

    go.drugbank.com/drugs/DB00683
    ApprovedIllicitInvestigational

    [F2977] This drug was initially approved by the US FDA in 1985, and has been approved for various indications since. … and endoscopic procedures as pre-anesthetic medication, and as an adjunct to local anesthesia.

    Products: Midazolam Injection USP, Midazolam Injection, USP
  7. Drug

    Hydrocortisone acetate

    go.drugbank.com/drugs/DB14539
    ApprovedInvestigationalVet approved

    Mixtures: Coly-Mycin S, Coly-Mycin SProducts: U-Cort, Jamp Hydrocortisone Cream USP 0.5%
  8. Drug

    Fenofibrate

    go.drugbank.com/drugs/DB01039
    ApprovedInvestigational

    Fenofibrate is a fibric acid derivative like [clofibrate] and [gemfibrozil].[A185954] Fenofibrate is used to treat primary hypercholesterolemia, mixed dyslipidemia, severe hypertriglyceridemia.

    Products: Lipimac 145 (Fenofibrate Film Coated Tablets USP 145 mg), Fenofibrate-S
  9. Drug

    Amiodarone

    go.drugbank.com/drugs/DB01118
    ApprovedInvestigational

    Amiodarone is a benzofuran derivative, anti-arrhythmic drug used commonly in a variety of settings. … Because of its ability to cause serious toxicity and possibly death, amiodarone use should be reserved for its approved indications, according to prescribing information.[L3561,L11265,L11286]

    Products: Amiodarone Hydrochloride for Injection, USP
  10. Drug

    Montelukast

    go.drugbank.com/drugs/DB00471
    ApprovedInvestigational

    Montelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair. … [L6301,L6304,L6307,L6310,L6325,L6328,L6331] Although capable of demonstrating effectiveness, the use of such LTRAs like montelukast is typically in addition to or complementary with the use of inhaled

    Products: Apo-Montelukast Tablets USP 10mg, APO-MONTELUKAST CHEWABLE TABLET 4MG USP